Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Anaesthesiol ; 29(9): 446-51, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22828385

ABSTRACT

CONTEXT: Standardised drug syringe labelling may reduce drug errors, but data on drug syringe labelling use in European anaesthesiology departments are lacking. OBJECTIVES: Survey investigating if standardised drug syringe labelling is used, and if there are geographical, demographic and professional differences in hospitals with and without use of drug syringe labelling. DESIGN: Structured, web-based anonymised questionnaire. SETTING: European anaesthesia departments. PARTICIPANTS: Members of the European Society of Anaesthesiology. INTERVENTION: Online survey from 2 February to 12 April 2011. MAIN OUTCOME MEASURE: Standardised drug syringe labelling use and, if yes, drug syringe labelling for insulin and norepinephrine. METHODS: Descriptive and comparative analyses of users and nonusers of standardised drug syringe labelling. RESULTS: One thousand and sixty-four of 4163 members (25.6%) from 72 countries participated, among whom 660 (62.0%) used standardised drug syringe labelling; in Northern and Western Europe, there were 428 users of drug syringe labelling and 112 nonusers, and in Southern and Eastern Europe, there were 184 users and 255 nonusers (P < 0.001). Three hundred and ninety-four (37%) respondents used standardised drug syringe labelling hospital-wide; 202 (30.1%) used International Organisation of Standardisation-based standardised drug syringe labelling, 101 (15.1%) used similar systems, 278 (41.5%) used other systems and 89 (13.3%) used labels supplied by drug manufacturers. The label colour for insulin was reported as white or 'none' in 519 (76.7%) answers and another colour in 158 (23.3%). The label colour for norepinephrine was reported as violet in 206 (30.4%) answers, white or 'none' in 226 (33.3%), red in 114 (16.8%) and another colour in 132 (19.5%). A standardised drug syringe labelling system supplied by the pharmaceutical industry was supported by 819 (76.9%) respondents, and not supported by 227 (21.3%). CONCLUSION: A majority of European anaesthesiology departments used standardised drug syringe labelling, with regional differences and mostly without following an international standard. Thus, there are options for quality improvement in drug syringe labelling.


Subject(s)
Anesthesiology , Drug Labeling/standards , Syringes , Drug Industry , Europe , Humans , Surveys and Questionnaires
2.
Intensive Care Med ; 38(8): 1298-305, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22527084

ABSTRACT

PURPOSE: Standardised coloured drug labels may increase patient safety in the intensive care unit (ICU). The rates of adherence to standardised drug syringe labelling (DSL) in European and non-European ICUs, and the standards applied are not known. The aim of this survey among ESICM members was to assess if and what standardised drug syringe labelling is used, if the standards for drug syringe labelling are similar internationally and if intensivists expect that standardised DSL should be delivered by the pharmaceutical industry. METHODS: A structured, web-based, anonymised survey on standardised DSL, performed among ESICM members (March-May 2011; Clinicaltrials.gov NCT01232088). Descriptive data analysis was performed and Fisher's exact test was applied where applicable. RESULTS: Four hundred eighty-two submissions were analysed (20 % non-European). Thirty-five percent of the respondents reported that standardised drug labelling was used hospital-wide, and 39 % reported that standardised DSL was used in their ICU (Europe: Northern 53 %, Western 52 %, Eastern 17 %, Southern 22 %). The International Organization of Standardization (ISO) 26825 norm in its original form was used by 30 %, an adapted version by 19 % and local versions by 45 %; 6 % used labels that were included in the drug's packaging. Eighty percent wished that the pharmaceutical industry supplied ISO 26825 norm labelling together with the drugs. CONCLUSIONS: Standardised DSL is not widely applied in European and non-European ICUs and mostly does not adhere strictly to the ISO norm. The frequency and quality of DSL differs to a great extent among European regions. This leaves much room for improvement.


Subject(s)
Drug Labeling/standards , Intensive Care Units , Syringes , Adrenergic beta-1 Receptor Agonists , Color , Dobutamine , Europe , Humans , Hypoglycemic Agents , Insulin , Internationality , Medication Errors/prevention & control , Norepinephrine , Patient Safety , Surveys and Questionnaires , Sympathomimetics
SELECTION OF CITATIONS
SEARCH DETAIL
...